IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.340
AS - Asia 1.012
EU - Europa 817
SA - Sud America 155
AF - Africa 51
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.283
IT - Italia 441
SG - Singapore 390
CN - Cina 167
IN - India 121
BR - Brasile 117
DE - Germania 91
GB - Regno Unito 90
VN - Vietnam 69
BD - Bangladesh 44
FI - Finlandia 41
HK - Hong Kong 41
CA - Canada 34
NL - Olanda 28
ID - Indonesia 25
PK - Pakistan 25
JO - Giordania 23
SE - Svezia 22
SA - Arabia Saudita 20
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
FR - Francia 13
EG - Egitto 12
IQ - Iraq 12
CO - Colombia 11
UA - Ucraina 11
AR - Argentina 9
JP - Giappone 9
MY - Malesia 9
RU - Federazione Russa 9
TR - Turchia 9
CZ - Repubblica Ceca 8
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
IR - Iran 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PT - Portogallo 7
KE - Kenya 6
AT - Austria 5
ET - Etiopia 5
KR - Corea 5
LB - Libano 5
PL - Polonia 5
RO - Romania 5
CY - Cipro 4
EC - Ecuador 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CH - Svizzera 3
GT - Guatemala 3
MA - Marocco 3
PH - Filippine 3
VE - Venezuela 3
AL - Albania 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.385
Salva come PNG Salva come JPEG
Città #
San Jose 255
Singapore 195
Ashburn 164
Chandler 110
Dallas 73
Santa Clara 64
Munich 63
Bengaluru 47
Hefei 46
Chicago 44
London 44
Beijing 33
Hong Kong 31
Milan 31
Turku 29
New York 25
Lawrence 24
Los Angeles 24
Princeton 24
Ho Chi Minh City 23
Rome 21
Catanzaro 18
Hanoi 16
Amman 15
Naples 15
Boardman 14
Jeddah 14
Council Bluffs 13
Carbonia 12
Helsinki 12
Parma 12
San Nicola Manfredi 12
São Paulo 12
San Francisco 11
Montreal 10
Spezzano della Sila 10
Atlanta 9
Chennai 9
Palermo 9
Wilmington 9
Buffalo 8
Catania 8
Delhi 8
Frankfurt am Main 8
Irbid 8
Madrid 8
Bologna 7
Cosenza 7
Des Moines 7
Kaunas 7
Ottawa 7
Tokyo 7
Afragola 6
Da Nang 6
Ercolano 6
Hyderabad 6
Kuala Lumpur 6
Riyadh 6
Santo Stefano di Rogliano 6
Sezze 6
Ahmedabad 5
Brooklyn 5
Cape Town 5
Cardiff 5
Dublin 5
Haiphong 5
Kyiv 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Nairobi 5
Olomouc 5
Orem 5
Pune 5
Sacramento 5
Seattle 5
Warsaw 5
Addis Ababa 4
Biên Hòa 4
Dhaka 4
Hanover 4
Islamabad 4
Istanbul 4
Johannesburg 4
Lima 4
Manchester 4
Melbourne 4
Nicosia 4
Oristano 4
Perugia 4
Redmond 4
Stockholm 4
Tanta 4
Tashkent 4
The Dalles 4
Toronto 4
Tubarão 4
West Jordan 4
Acquaviva delle Fonti 3
Ajman 3
Totale 1.915
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 487
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 142
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 117
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 115
miR-22 suppresses DNA ligase III addiction in multiple myeloma 103
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 100
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 94
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 88
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 81
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 80
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 79
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 76
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 75
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 75
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 75
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 73
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 73
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 71
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 70
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 68
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 66
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 65
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 64
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 63
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 59
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 58
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 57
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 56
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 55
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 51
Mmrf-commpass data integration and analysis for identifying prognostic markers 51
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 51
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 50
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 48
Ethical Perspectives on Pharmacogenomic Profiling 47
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 46
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 45
null 43
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 42
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 40
The EASY-NET research programme: background, structure, and methodology 37
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 37
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 36
The potential role of miRNAs in multiple myeloma therapy 34
null 31
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 30
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 13
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 12
null 4
Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke 3
Totale 3.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.914
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.914
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022126 3 0 0 22 5 0 4 21 34 15 17 5
2022/2023394 55 25 28 13 45 26 6 25 49 40 55 27
2023/2024476 90 33 42 39 45 71 25 41 10 18 27 35
2024/2025876 75 20 27 37 64 119 64 55 55 21 142 197
2025/20261.529 108 154 126 149 168 80 211 74 157 147 96 59
Totale 3.497